← Leaderboards
Michel M Ouellette
University Of Nebraska Medical Center
$1,992,405
Attributed
$2,923,646
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $374.7K · FY2008–20$500K$375K$250K$125K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$2,923,646 · 2
By mechanism
R01$1,862,482 · 1
P50$1,061,164 · 1
Top collaborators
- Surinder Kumar Batra5 shared
Most similar at University Of Nebraska Medical Center
Same institution · by research overlap
- Suyong Choi$1,627,271
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsGrowthTumorTumor GrowthNeoplasm MetastasisBaseMalignant Neoplasm Of PancreasPancreasTelomeraseCellsPropertyAnimalsPancreatic Cancer CellsAutopsyCancer Cell LineDoseCancer CellAdvanced Malignant NeoplasmClinical TreatmentDrug DesignCessation Of LifeBioluminescenceCollaborationsBinding (Molecular Function)
Grant awards (10)
Rac1 GTPase in tumorigenesis and progression of pancreatic cancer$374,745
R01 · FY2020 · CA · contact PI
Rac1 GTPase in tumorigenesis and progression of pancreatic cancer$363,502
R01 · FY2019 · CA · contact PI
Rac1 GTPase in tumorigenesis and progression of pancreatic cancer$374,745
R01 · FY2018 · CA · contact PI
Rac1 GTPase in tumorigenesis and progression of pancreatic cancer$374,745
R01 · FY2017 · CA · contact PI
Rac1 GTPase in tumorigenesis and progression of pancreatic cancer$374,745
R01 · FY2016 · CA · contact PI
P-4: Inhibitors of telomerase in treatment of Pancreatic Adenocarcinoma$227,493
P50 · FY2012 · CA · contact PI
P-4: Inhibitors of telomerase in treatment of Pancreatic Adenocarcinoma$202,499
P50 · FY2011 · CA · contact PI
P-4: Inhibitors of telomerase in treatment of Pancreatic Adenocarcinoma$233,455
P50 · FY2010 · CA · contact PI
P-4: Inhibitors of telomerase in treatment of Pancreatic Adenocarcinoma$233,764
P50 · FY2009 · CA · contact PI
P-4: Inhibitors of telomerase in treatment of Pancreatic Adenocarcinoma$163,953
P50 · FY2008 · CA · contact PI